Spots Global Cancer Trial Database for parathyroid diseases
Every month we try and update this database with for parathyroid diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy | NCT05022667 | Thyroid Neoplas... Thyroid Disease... Hypoparathyroid... Endocrine Syste... Endocrine Gland... Neoplasms by Si... Neoplasms Head and Neck N... Parathyroid Dis... | PTeye | 18 Years - | University of Michigan | |
| Minimizing Narcotic Analgesics After Endocrine Surgery | NCT03469310 | Thyroid Cancer Thyroid Nodule Thyroid Neoplas... Thyroid Goitre Thyroid Disease... Parathyroid Dis... Parathyroid Ade... Parathyroid Hyp... | Acetaminophen 5... Tylenol #3 Oral... Tramadol | 18 Years - | DHR Health Institute for Research and Development | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | NCT01219855 | Chronic Kidney ... Secondary Hyper... Vitamin D Insuf... | Cohort 1 CTAP10... Cohort 1 CTAP10... Cohort 1 Matchi... Cohort 2 CTAP10... Cohort 2 Matchi... | 18 Years - 85 Years | OPKO Health, Inc. | |
| Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | NCT01704079 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 30 μg c... Sugar pill to C... | 18 Years - | OPKO Health, Inc. | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | NCT01651000 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 30 μg c... Sugar pill to C... | 18 Years - | OPKO Health, Inc. | |
| Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy | NCT05152927 | Parathyroid Dis... Parathyroid Dys... Parathyroid Neo... Parathyroid Ade... Hypercalcemia Neoplasms, Glan... Endocrine Gland... Adenoma Hyperparathyroi... Hyperparathyroi... | Parathyroid Eye... | 18 Years - | University of California, San Francisco | |
| Latest Imaging SPECT System Evaluation Phase 1 | NCT04704349 | Rheumatic Disea... Neoplasms Parathyroid Dis... Pulmonary Embol... Heart Diseases Thyroid Disease... Kidney Diseases Dementia Parkinsonian Di... | Scintigraphy | 18 Years - | Centre Hospitalier Régional d'Orléans | |
| Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | NCT01219855 | Chronic Kidney ... Secondary Hyper... Vitamin D Insuf... | Cohort 1 CTAP10... Cohort 1 CTAP10... Cohort 1 Matchi... Cohort 2 CTAP10... Cohort 2 Matchi... | 18 Years - 85 Years | OPKO Health, Inc. | |
| Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) | NCT00792857 | Chronic Kidney ... Secondary Hyper... Chronic Renal I... Chronic Renal F... | CTAP201 Injecti... Doxercalciferol | 18 Years - 80 Years | OPKO Health, Inc. | |
| Latest Imaging SPECT System Evaluation Phase 1 | NCT04704349 | Rheumatic Disea... Neoplasms Parathyroid Dis... Pulmonary Embol... Heart Diseases Thyroid Disease... Kidney Diseases Dementia Parkinsonian Di... | Scintigraphy | 18 Years - | Centre Hospitalier Régional d'Orléans | |
| Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas | NCT00639405 | Parathyroid Neo... Parathyroid Dis... | 18 Years - 80 Years | State University of New York - Upstate Medical University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
